Interventions for Tuberculosis Control and Elimination 2002

973. Iseman MD, Madsen L, Goble M, Pomerantz M. Surgical intervention in the
treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis.
Am Rev Respir Dis 1990; 141: 623-5.
974. Pomerantz M, Madsen L, Goble M, Iseman M. Surgical management of resistant
mycobacterial tuberculosis and other mycobacterial pulmonary infections.
Ann Thoracic Surg 1991; 52: 1108-12.
975. Nitta AT, Iseman MD, Newell JD, Madsen LA, Goble M. Ten-year experience
with artificial pneumoperitoneum for end-stage, drug-resistant pulmonary tuberculosis.
Clin Infect Dis 1993; 16: 219-22.
976. Veen J. Drug resistant tuberculosis: back to sanatoria, surgery and cod-liver oil?
(Editorial). Eur Respir J 1995; 8: 1073-5.
977. Agarwal SK, Roy DC, Jha N. Empyema thoracis: a review of 70 cases. Ind J
Chest Dis All Sci 1985; 27: 17-22.
978. Blanco-Perez J, Bordón J, Piñeiro-Amigo L, Roca-Serrano R, Izquierdo R, Abal-
Arca J. Pneumothorax in active pulmonary tuberculosis: resurgence of an old
complication? Respir Med 1998; 92: 1269-73.
979. Elliott AM, Berning SE, Iseman MD, Peloquin CA. Failure of drug penetration
and acquisition of drug resistance in chronic tuberculous empyema.
Lung Dis 1995; 76: 463-7.
Tubercle
980. Janssens JP, de Haller R. Spinal tuberculosis in a developed country. A review
of 26 cases with special emphasis on abscesses and neurologic complications.
Clin Orthop Rel Res 1990; 257: 67-75.
981. Heymann SJ, Brewer TF, Wilson ME, Fineberg HV. The need for global action
against multidrug-resistant tuberculosis.
2138-40.
(Commentary). JAMA 1999; 281:
982. Horsburgh CR, Jr. The global problem of muldtidrug-resistant tuberculosis. The
genie is out of the bottle. (Editorial). JAMA 2000; 283: 2575-6.
983. Iseman MD. Tuberculosis control strategies and utilitarianism. (Editorial). Int
J Tuberc Lung Dis 2000; 4: 95.
984. Kawaguchi H. Discovery, chemistry, and activity of amikacin. J Infect Dis
1976; 134 (Suppl): S242-S248.
985. Kawaguchi H, Naito T, Nakagawa S, Fujisawa K. BB-K 8, a new semisynthetic
aminoglycoside antibiotic. J Antibiotics 1972; 25: 695-708.
986. Edson RS, Terrell CL. The aminoglycosides. Mayo Clin Proc 1999; 74: 519-28.
987. Garcia Rodriguez JA, Martin Luengo F, Saenz Gonzalez MC. Activity of
amikacin against Mycobacterium tuberculosis.
Chemother 1978; 4: 293-4.
(Correspondence). J Antimicrob
988. Allen BW, Mitchison DA, Chan YC, Yew WW, Allan WGL, Girling DJ. Amikacin
in the treatment of pulmonary tuberculosis. Tubercle 1983; 64: 111-8.
235